Literature DB >> 20557739

Rate of Recanalization and Safety of Endovascular Embolization of Intracranial Saccular Aneurysms Framed with GDC 360 Coils.

R Ortiz1, J Song, Y Niimi, A Berenstein.   

Abstract

SUMMARY: Coil compaction and recanalization of cerebral aneurysms treated with coil embolization continue to be of great concern, especially in patients that presented with subarachnoid hemorrhage. The incidence of recanalization reported by previous studies ranges from 12 to 40 percent in experienced centers. We reviewed the incidence of recanalization requiring retreatment in patients treated with GDC 360 framing coils. A retrospective review of every patient who underwent coil embolization with GDC 360 coils for saccular aneurysms at our institution from December 2004 to March 2008 was performed. We studied the patients' demographics, clinical presentation, aneurysm size and configuration, type of coils used to embolize the aneurysm, the percentage of coils that were GDC 360 in any given aneurysm, the need for remodeling techniques like stent and/or balloon for embolization, immediate complications, cases in which we were unable to frame with the GDC 360 coil, and rate of recanalization on follow- up. A total of 110 patients (33 men, 77 women) and 114 aneurysms were treated with GDC 360 coils. Ninety-eight aneurysms were framed with the GDC 360 coils. There were two patients in whom the initial GDC 360 coil intended for framing had to be pulled out and exchanged for another type of coil. There were five procedure related complications (4.4%). Four patients required intra-arterial abciximab due to thrombus formation. One patient that presented with a grade III subarachnoid hemorrhage had aneurysm rupture while the coil was being advanced. A total of 50 patients (15 men and 35 women) underwent follow-up femoral cerebral angiograms at least six months after coiling (mean follow-up was 15 months). Forty-four of the patients with follow-up had the GDC 360 coil used as a framing coil. Three patients (6%) required retreatment due to recanalization. Every patient with recanalization requiring treatment had aneurysms of the anterior communicating complex that presented with subarachnoid hemorrhage. The rate of recanalization of cerebral aneurysms embolized with GDC 360 framing coils was lower in our case series compared to the existing literature reports. Patients with aneurysms of the anterior communicating artery were at increased incidence of recanalization in our patient cohort.

Entities:  

Year:  2009        PMID: 20557739      PMCID: PMC3313807          DOI: 10.1177/159101990801400405

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  11 in total

1.  Cerecyte coils in the treatment of intracranial aneurysms: a preliminary clinical study.

Authors:  M Bendszus; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Hydrogel-coated coils for the treatment of cerebral aneurysms: preliminary results.

Authors:  Adam S Arthur; Stephanie A Wilson; Sanat Dixit; John D Barr
Journal:  Neurosurg Focus       Date:  2005-02-15       Impact factor: 4.047

3.  Angiographic follow-up of cerebral aneurysms treated with Guglielmi detachable coils: an analysis of 162 cases with 173 aneurysms.

Authors:  M-H Li; B-L Gao; C Fang; B-X Gu; Y-S Cheng; W Wang; G Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  Endovascular treatment of basilar artery trunk aneurysms with Guglielmi detachable coils: clinical experience with 41 aneurysms in 39 patients.

Authors:  K Uda; Y Murayama; Y P Gobin; G R Duckwiler; F Viñuela
Journal:  J Neurosurg       Date:  2001-10       Impact factor: 5.115

5.  Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience.

Authors:  A Berenstein; J K Song; Y Niimi; K Namba; N S Heran; J L Brisman; M C Nahoum; M Madrid; D J Langer; M J Kupersmith
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

6.  Repeat endovascular treatment in post-embolization recurrent intracranial aneurysms.

Authors:  Hyun-Seung Kang; Moon Hee Han; Bae Ju Kwon; O-Ki Kwon; Sung Hyun Kim
Journal:  Neurosurgery       Date:  2006-01       Impact factor: 4.654

7.  Packing performance of GDC 360 degrees coils in intracranial aneurysms: a comparison with complex orbit coils and helical GDC 10 coils.

Authors:  W J van Rooij; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

8.  Endovascular coil embolization of intracranial aneurysms: important factors related to rates and outcomes of incomplete occlusion.

Authors:  Max K Kole; David M Pelz; Paul Kalapos; Donald H Lee; Irene B Gulka; Stephen P Lownie
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

9.  Initial experience with bioactive cerecyte detachable coils: impact on reducing recurrence rates.

Authors:  Erol Veznedaroglu; Christopher J Koebbe; Adnan Siddiqui; Robert H Rosenwasser
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

10.  Cigarette smoking as a risk factor for recurrence of aneurysms treated by endosaccular occlusion.

Authors:  Rafael Ortiz; Michael Stefanski; Robert Rosenwasser; Erol Veznedaroglu
Journal:  J Neurosurg       Date:  2008-04       Impact factor: 5.115

View more
  3 in total

1.  Extended monitoring of coiled aneurysms completely occluded at 6-month follow-up: late recanalization rate and related risk factors.

Authors:  Jin Pyeong Jeon; Young Dae Cho; Jong Kook Rhim; Dong Hyun Yoo; Hyun-Seung Kang; Jeong Eun Kim; Won-Sang Cho; Moon Hee Han
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

2.  Flow diversion versus traditional endovascular coiling therapy: design of the prospective LARGE aneurysm randomized trial.

Authors:  A S Turk; R H Martin; D Fiorella; J Mocco; A Siddiqui; A Bonafe
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

3.  Multiple overlapping stent-assisted coiling improves efficacy and safety of treatment for complex intracranial aneurysms: a randomized trial.

Authors:  Lingtong You; Jiaxin Huang; Jinning Zhang; Zhixian Jiang
Journal:  Biomed Eng Online       Date:  2021-10-09       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.